# Prime Medicine, Inc. (PRME) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Prime Medicine, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PRME/mda/fy2025/): filed 2026-03-03; accession 0001628280-26-013569 (https://www.sec.gov/Archives/edgar/data/1894562/000162828026013569/prme-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/PRME/mda/fy2024/): filed 2025-02-28; accession 0001628280-25-008884 (https://www.sec.gov/Archives/edgar/data/1894562/000162828025008884/prme-20241231.htm)
- [FY 2023 MD&A](/company/PRME/mda/fy2023/): filed 2024-03-01; accession 0001628280-24-008116 (https://www.sec.gov/Archives/edgar/data/1894562/000162828024008116/prme-20231231.htm)
- [FY 2022 MD&A](/company/PRME/mda/fy2022/): filed 2023-03-09; accession 0001628280-23-007266 (https://www.sec.gov/Archives/edgar/data/1894562/000162828023007266/prme-20221231.htm)

Back to /company/PRME/